ADESSO SE (ADN1.DE) Fundamental Analysis & Valuation

FRA:ADN1 • DE000A0Z23Q5

Current stock price

59.4 EUR
+2.7 (+4.76%)
Last:

This ADN1.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ADN1.DE Profitability Analysis

1.1 Basic Checks

  • ADN1 had positive earnings in the past year.
  • ADN1 had a positive operating cash flow in the past year.
  • Each year in the past 5 years ADN1 has been profitable.
  • ADN1 had a positive operating cash flow in each of the past 5 years.
ADN1.DE Yearly Net Income VS EBIT VS OCF VS FCFADN1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

  • ADN1's Return On Assets of 2.45% is on the low side compared to the rest of the industry. ADN1 is outperformed by 64.00% of its industry peers.
  • With a Return On Equity value of 10.90%, ADN1 perfoms like the industry average, outperforming 46.67% of the companies in the same industry.
  • ADN1's Return On Invested Capital of 5.23% is on the low side compared to the rest of the industry. ADN1 is outperformed by 65.33% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ADN1 is significantly below the industry average of 27.67%.
  • The 3 year average ROIC (3.16%) for ADN1 is below the current ROIC(5.23%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.45%
ROE 10.9%
ROIC 5.23%
ROA(3y)1.93%
ROA(5y)3.99%
ROE(3y)6.49%
ROE(5y)13.12%
ROIC(3y)3.16%
ROIC(5y)4.51%
ADN1.DE Yearly ROA, ROE, ROICADN1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

  • With a Profit Margin value of 0.99%, ADN1 is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • ADN1's Profit Margin has declined in the last couple of years.
  • The Operating Margin of ADN1 (2.96%) is worse than 69.33% of its industry peers.
  • In the last couple of years the Operating Margin of ADN1 has declined.
  • Looking at the Gross Margin, with a value of 85.30%, ADN1 is in the better half of the industry, outperforming 76.00% of the companies in the same industry.
  • ADN1's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.96%
PM (TTM) 0.99%
GM 85.3%
OM growth 3Y-30%
OM growth 5Y-15.03%
PM growth 3Y-55.28%
PM growth 5Y-30.54%
GM growth 3Y-0.02%
GM growth 5Y-0.7%
ADN1.DE Yearly Profit, Operating, Gross MarginsADN1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ADN1.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ADN1 is creating some value.
  • The number of shares outstanding for ADN1 has been reduced compared to 1 year ago.
  • ADN1 has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ADN1 has an improved debt to assets ratio.
ADN1.DE Yearly Shares OutstandingADN1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ADN1.DE Yearly Total Debt VS Total AssetsADN1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 3.44 indicates that ADN1 is not in any danger for bankruptcy at the moment.
  • ADN1 has a better Altman-Z score (3.44) than 80.00% of its industry peers.
  • ADN1 has a debt to FCF ratio of 7.88. This is a slightly negative value and a sign of low solvency as ADN1 would need 7.88 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 7.88, ADN1 is doing worse than 68.00% of the companies in the same industry.
  • A Debt/Equity ratio of 1.60 is on the high side and indicates that ADN1 has dependencies on debt financing.
  • ADN1's Debt to Equity ratio of 1.60 is on the low side compared to the rest of the industry. ADN1 is outperformed by 77.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.6
Debt/FCF 7.88
Altman-Z 3.44
ROIC/WACC1.03
WACC5.09%
ADN1.DE Yearly LT Debt VS Equity VS FCFADN1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

  • ADN1 has a Current Ratio of 1.30. This is a normal value and indicates that ADN1 is financially healthy and should not expect problems in meeting its short term obligations.
  • ADN1's Current ratio of 1.30 is in line compared to the rest of the industry. ADN1 outperforms 56.00% of its industry peers.
  • ADN1 has a Quick Ratio of 1.30. This is a normal value and indicates that ADN1 is financially healthy and should not expect problems in meeting its short term obligations.
  • ADN1 has a Quick ratio (1.30) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 1.3
ADN1.DE Yearly Current Assets VS Current LiabilitesADN1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. ADN1.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 200.98% over the past year.
  • The earnings per share for ADN1 have been decreasing by -15.02% on average. This is quite bad
  • Looking at the last year, ADN1 shows a quite strong growth in Revenue. The Revenue has grown by 12.60% in the last year.
  • Measured over the past years, ADN1 shows a very strong growth in Revenue. The Revenue has been growing by 23.60% on average per year.
EPS 1Y (TTM)200.98%
EPS 3Y-45.14%
EPS 5Y-15.02%
EPS Q2Q%9.8%
Revenue 1Y (TTM)12.6%
Revenue growth 3Y24.12%
Revenue growth 5Y23.6%
Sales Q2Q%13.44%

3.2 Future

  • Based on estimates for the next years, ADN1 will show a very strong growth in Earnings Per Share. The EPS will grow by 40.90% on average per year.
  • Based on estimates for the next years, ADN1 will show a quite strong growth in Revenue. The Revenue will grow by 10.64% on average per year.
EPS Next Y79.75%
EPS Next 2Y69.09%
EPS Next 3Y57.86%
EPS Next 5Y40.9%
Revenue Next Year11.29%
Revenue Next 2Y11.26%
Revenue Next 3Y11.01%
Revenue Next 5Y10.64%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ADN1.DE Yearly Revenue VS EstimatesADN1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
ADN1.DE Yearly EPS VS EstimatesADN1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. ADN1.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 18.62, the valuation of ADN1 can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of ADN1 is on the same level as its industry peers.
  • ADN1's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.18.
  • The Price/Forward Earnings ratio is 11.39, which indicates a very decent valuation of ADN1.
  • ADN1's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ADN1 is cheaper than 70.67% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 37.96. ADN1 is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 18.62
Fwd PE 11.39
ADN1.DE Price Earnings VS Forward Price EarningsADN1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ADN1 is valued a bit cheaper than 77.33% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ADN1 indicates a somewhat cheap valuation: ADN1 is cheaper than 73.33% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.3
EV/EBITDA 5.07
ADN1.DE Per share dataADN1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300

4.3 Compensation for Growth

  • ADN1's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ADN1's earnings are expected to grow with 57.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y69.09%
EPS Next 3Y57.86%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ADN1.DE Dividend Analysis

5.1 Amount

  • ADN1 has a Yearly Dividend Yield of 1.41%.
  • The stock price of ADN1 dropped by -36.29% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • Compared to an average industry Dividend Yield of 2.80, ADN1 has a dividend in line with its industry peers.
  • Compared to the average S&P500 Dividend Yield of 1.82, ADN1 is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.41%

5.2 History

  • On average, the dividend of ADN1 grows each year by 15.65%, which is quite nice.
Dividend Growth(5Y)15.65%
Div Incr Years1
Div Non Decr Years7
ADN1.DE Yearly Dividends per shareADN1.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • 31.75% of the earnings are spent on dividend by ADN1. This is a low number and sustainable payout ratio.
  • ADN1's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP31.75%
EPS Next 2Y69.09%
EPS Next 3Y57.86%
ADN1.DE Yearly Income VS Free CF VS DividendADN1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ADN1.DE Dividend Payout.ADN1.DE Dividend Payout, showing the Payout Ratio.ADN1.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ADN1.DE Fundamentals: All Metrics, Ratios and Statistics

ADESSO SE

FRA:ADN1 (4/14/2026, 3:41:59 PM)

59.4

+2.7 (+4.76%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)03-31
Earnings (Next)05-11
Inst Owners19.56%
Inst Owner ChangeN/A
Ins Owners50.29%
Ins Owner ChangeN/A
Market Cap387.88M
Revenue(TTM)2.10B
Net Income(TTM)20.84M
Analysts83.33
Price Target126.99 (113.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.41%
Yearly Dividend0.94
Dividend Growth(5Y)15.65%
DP31.75%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.61%
PT rev (3m)0.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.07%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.68%
Valuation
Industry RankSector Rank
PE 18.62
Fwd PE 11.39
P/S 0.18
P/FCF 8.3
P/OCF 4.99
P/B 2.03
P/tB 7.66
EV/EBITDA 5.07
EPS(TTM)3.19
EY5.37%
EPS(NY)5.21
Fwd EY8.78%
FCF(TTM)7.16
FCFY12.05%
OCF(TTM)11.9
OCFY20.03%
SpS322.11
BVpS29.27
TBVpS7.75
PEG (NY)0.23
PEG (5Y)N/A
Graham Number45.84
Profitability
Industry RankSector Rank
ROA 2.45%
ROE 10.9%
ROCE 11.91%
ROIC 5.23%
ROICexc 5.78%
ROICexgc 8.22%
OM 2.96%
PM (TTM) 0.99%
GM 85.3%
FCFM 2.22%
ROA(3y)1.93%
ROA(5y)3.99%
ROE(3y)6.49%
ROE(5y)13.12%
ROIC(3y)3.16%
ROIC(5y)4.51%
ROICexc(3y)4.06%
ROICexc(5y)6.01%
ROICexgc(3y)6.65%
ROICexgc(5y)10.11%
ROCE(3y)7.2%
ROCE(5y)10.26%
ROICexgc growth 3Y-20.34%
ROICexgc growth 5Y-12.01%
ROICexc growth 3Y-21.84%
ROICexc growth 5Y-11.01%
OM growth 3Y-30%
OM growth 5Y-15.03%
PM growth 3Y-55.28%
PM growth 5Y-30.54%
GM growth 3Y-0.02%
GM growth 5Y-0.7%
F-Score7
Asset Turnover2.47
Health
Industry RankSector Rank
Debt/Equity 1.6
Debt/FCF 7.88
Debt/EBITDA 2.26
Cap/Depr 42.37%
Cap/Sales 1.47%
Interest Coverage 5.03
Cash Conversion 57.42%
Profit Quality 224.33%
Current Ratio 1.3
Quick Ratio 1.3
Altman-Z 3.44
F-Score7
WACC5.09%
ROIC/WACC1.03
Cap/Depr(3y)52.06%
Cap/Depr(5y)49.68%
Cap/Sales(3y)2.64%
Cap/Sales(5y)2.54%
Profit Quality(3y)790.41%
Profit Quality(5y)538.39%
High Growth Momentum
Growth
EPS 1Y (TTM)200.98%
EPS 3Y-45.14%
EPS 5Y-15.02%
EPS Q2Q%9.8%
EPS Next Y79.75%
EPS Next 2Y69.09%
EPS Next 3Y57.86%
EPS Next 5Y40.9%
Revenue 1Y (TTM)12.6%
Revenue growth 3Y24.12%
Revenue growth 5Y23.6%
Sales Q2Q%13.44%
Revenue Next Year11.29%
Revenue Next 2Y11.26%
Revenue Next 3Y11.01%
Revenue Next 5Y10.64%
EBIT growth 1Y38.36%
EBIT growth 3Y-13.12%
EBIT growth 5Y5.01%
EBIT Next Year308.27%
EBIT Next 3Y79.99%
EBIT Next 5Y45.14%
FCF growth 1Y300.77%
FCF growth 3Y40.19%
FCF growth 5Y49.54%
OCF growth 1Y1010.67%
OCF growth 3Y32.14%
OCF growth 5Y37.69%

ADESSO SE / ADN1.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ADESSO SE (ADN1.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ADN1.DE.


Can you provide the valuation status for ADESSO SE?

ChartMill assigns a valuation rating of 6 / 10 to ADESSO SE (ADN1.DE). This can be considered as Fairly Valued.


How profitable is ADESSO SE (ADN1.DE) stock?

ADESSO SE (ADN1.DE) has a profitability rating of 4 / 10.


What is the financial health of ADESSO SE (ADN1.DE) stock?

The financial health rating of ADESSO SE (ADN1.DE) is 4 / 10.


Can you provide the dividend sustainability for ADN1 stock?

The dividend rating of ADESSO SE (ADN1.DE) is 5 / 10 and the dividend payout ratio is 31.75%.